Megan Healey, PhD, MPH
Clinical Assistant Professor
Boston University School of Public Health
Dept of Epidemiology

MPH, Harvard School of Public Health
PhD, Johns Hopkins University School of Medicine



Megan Healey, PhD, MPH is a molecular epidemiologist with expertise in epigenetics and breast cancer. Dr. Healey uses population-based studies to investigate molecular and behavioral determinants of cancer subtypes and prognosis. Trained as a bench scientist, Dr. Healey completed research fellowships in cancer epigenetics at Johns Hopkins and cancer epidemiology at Harvard. She transitioned from biomedical science to public health in hopes of leveraging her interdisciplinary background to improve the health of populations. Part of that mission is to help train our future leaders in public health. Dr. Healey is invested in bringing innovative, integrated and practical approaches to learning in the classroom, particularly in large courses. Currently, Dr. Healey teaches Quantitative Methods for Public Health, Concepts and Methods in Epidemiology and Nutritional Epidemiology. In 2017, she received the BUSPH Educational Innovation Award and is the recipient of several BUSPH Excellence in Teaching Awards. Dr. Healey also serves as co-director of the MPH Certificate in Epidemiology and Biostatistics.
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Healey MA, Hu R, Beck AH, Collins LC, Schnitt SJ, Tamimi RM, Hazra A. Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses'' Health Study. Breast Cancer Res Treat. 2014 Oct; 147(3):639-51. PMID: 25224916; DOI: 10.1007/s10549-014-3089-1;.
  2. Hossain MZ, Healey MA, Lee C, Poh W, Yerram SR, Patel K, Azad NS, Herman JG, Kern SE. DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cells. Oncotarget. 2013 Feb; 4(2):298-309. PMID: 23593653; PMCID: PMC3712575.
  3. Xu L, Wang SS, Healey MA, Faupel-Badger JM, Wilken JA, Battaglia T, Szabo E, Mao JT, Bergan RC. The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research. Cancer Prev Res (Phila). 2011 Apr; 4(4):616-21.View Related Profiles. PMID: 21464034; DOI: 10.1158/1940-6207.CAPR-11-0018;.
  4. Healey MA, Deaton SL, Alder JK, Winnepenninckx V, Casero RA, Herman JG. Id1 overexpression is independent of repression and epigenetic silencing of tumor suppressor genes in melanoma. Epigenetics. 2010 Jul 1; 5(5):410-21. PMID: 20484992; PMCID: PMC3654680.
  5. Cummings SD, Ryu B, Samuels MA, Yu X, Meeker AK, Healey MA, Alani RM. Id1 delays senescence of primary human melanocytes. Mol Carcinog. 2008 Sep; 47(9):653-9.View Related Profiles. PMID: 18240291; DOI: 10.1002/mc.20422;.
  6. Ryu B, Kim DS, DeLuca AM, Healey MA, Dunlap S, Fackler MJ, Herman J, Alani RM. Id1 expression is transcriptionally regulated in radial growth phase melanomas. Int J Cancer. 2007 Oct 15; 121(8):1705-9.View Related Profiles. PMID: 17565736.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 6 publications over 6 distinct years, with a maximum of 1 publications in 2007 and 2008 and 2010 and 2011 and 2013 and 2014

YearPublications
20071
20081
20101
20111
20131
20141
Contact for Mentoring:


715 Albany St Talbot Building
Boston MA 02118
Google Map


Healey's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_